14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma

Cancer Research

Volumn 59, Issue 18, 1999, Pages 4546-4550

  Avet Loiseau, Hervé ^a,d   Facon, Thierry ^b   Daviet, Axelle ^a   Godon, Catherine ^a   Rapp, Marie José ^a   Harousseau, Jean Luc ^a   Grosbois, Bernard ^c   Bataille, Régis ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d INSTITUT DE BIOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARCINOGENESIS; CHROMOSOME 14Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME TRANSLOCATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 4; DISEASE PROGRESSION; GENE DELETION; HUMANS; MONOSOMY; MULTIPLE MYELOMA; PARAPROTEINEMIAS; TRANSLOCATION, GENETIC;

EID: 0033568514     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Kyle, R. A., and Lust, J. A. Monoclonal gammopathies of undetermined significance. Semin. Hematol., 26: 176-200, 1989.
2. Kyle, R. A. "Benign" monoclonal gammopathy: after 20 to 35 years of follow-up. Mayo Clin. Proc., 68: 26-36, 1993.
3. Blade, J., Lopez-Guillermo, A., Rozman, C., Cervantes, F., Salgado, C., Aguilar, J. L., Vives-Corrons, J. L., and Montserrat, E. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. Br. J. Haematol., 81: 391-394, 1992.
4. Ocqueteau, M., Orfao, A., Almeida, J., Blade, J., Gonzalez, M., Garcia-Sanz, R., Lopez-Berges, C., Moro, M. J., Hernandez, J., Escribano, L., Caballero, D., Rozman, M., and San Miguel, J. F. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. Am. J. Pathol., 152: 1655-1665, 1998.
5. Dewald, G. W., Kyle, R. A., Hicks, G. A., and Greipp, P. R. The clinical significance of cytogenetics studies in 100 patients with multiple myeloma, plasma cell leukemia or amyloidosis. Blood, 66: 380-390, 1985.
6. Gould, J., Alexanian, R., Goodacre, A., Pathak, S., Hecht, B., and Barlogie, B. Plasma cell karyotype in multiple myeloma. Blood, 71: 453-456, 1988.
7. Laï, J. L., Zandecki, M., Mary, J. Y., Bernardi, F., Izydorczyk, V., Flactif, M., Morel, P., Jouet, J. P., Bauters, F., and Facon, T. Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood, 85: 2490-2497, 1995.
8. Sawyer, J. R., Waldron, J. A., Jagannath, S., and Barlogie, B. Cytogenetics findings in 200 patients with multiple myeloma. Cancer Genet. Cytogenet., 82: 41-49, 1995.
9. Calasanz, M. J., Cigudosa, J. C., Odero, M. D., Ferreira, C., Ardanaz, M. T., Fraile, A., Carrasco, J. L., Sole, F., Cuesta, B., and Gullon, A. Cytogenetic analysis of 280 patients with multiple myeloma and related disorder: primary breakpoints and clinical correlations. Genes Chromosomes Cancer, 18: 84-93, 1997.
10. Drach, J., Angerler, J., Schuster, J., Rothermundt, C., Thalhammer, R., Haas, O. A., Jager, U., Fiegl, M., Geissler, K., Ludwig, H., and Huber, H. Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. Blood, 86: 3915-3921, 1995.
11. Zandecki, M., Obein, V., Bernardi, F., Soenen, V., Flactif, M., Laï, J. L., Francois, M., and Facon, T. Monoclonal gammopathy of undetermined significance: chromosome changes are a common finding within plasma cells. Br. J. Haematol., 90: 693-696, 1995.
12. Zandecki, M., Laï, J. L., Genevieve, F., Bernardi, F., Volle-Remy, H., Blanchet, O., Francois, M., Cosson, A., Bauters, F., and Facon, T. Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition. Blood, 90: 3682-3690, 1997.
13. Avet-Loiseau, H., Li, J. Y., Facon, T., Brigaudeau, C., Morineau, N., Maloisel, F., Rapp, M. J., Talmant. P., Trimoreau, F., Jaccard, A., Harousseau, J. L., and Bataille, R. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies. Cancer Res., 58: 5640-5645, 1998.
14. Nishida, K., Tamura, A., Nakazawa, N., Ueda, Y., Abe, T., Matsuda, F., Kashima, K., and Taniwaki, M. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood, 90: 526-534, 1997.
15. Avet-Loiseau, H., Li, J. Y., Morineau, N., Facon, T., Brigaudeau, C., Harousseau, J. L., Grosbois, B., and Bataille, R., on behalf of the Intergroupe Francophone du Myélome. Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Blood, 94: 1999.
16. Kyle, R. A., and Greipp, P. R. Smoldering multiple myeloma. N. Engl. J. Med., 302: 1347-1349, 1980.
17. Durie, B. G. M., and Salmon, S. E. Multiple myeloma, macroglobulinaemia and monoclonal gammopathies. In: A. V. Hoffbrand, M. C. Brain, and J. Hirsh (eds.), Recent Advances in Haematology, pp. 243-261. Edinburgh, London, New York: Churchill Livingstone, 1977.
18. Rack, K. A., Delabesse, E., Radford-Weiss, I., Bourquelot, P., Le Guyader, G., Vekemans, M., and Macintyre, E. A. Simultaneous detection of MYC, BVR1, and PVT1 translocations in lymphoid malignancies by fluorescence in situ hybridization. Genes Chromosomes Cancer, 23: 220-226, 1998.
19. Barlogie, B., Alexanian, R., Dixon, D., Smith, L., Smallwood, L., and Delasalle, K. Prognostic implications of tumor cell DNA and RNA content in multiple myeloma. Blood, 66: 338-342, 1985.
20. Zandecki, M., Bernardi, F., Laï, J. L., Facon, T., Izydorczyk, V., Bauters, F., and Cosson, A. Image analysis in multiple myeloma at diagnosis: correlation with cytogenetic study. Cancer Genet. Cytogenet., 74: 115-119, 1994.
21. Flactif, M., Zandecki, M., Laï, J. L., Bernardi, F., Obein, V., Bauters, F., and Facon, T. Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma. Leukemia (Baltimore), 9: 2109-2114, 1995.
22. Drach, J., Schuster, J., Nowotny, H., Angerler, J., Rosenthal, F., Fiegl, M., Rothermundt, C., Gsur, A., Jaeger, U., Heinz, R., Lechner, K., Ludwig, H., and Huber, H. Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization. Cancer Res., 55: 3854-3859, 1995.
23. Perez-Simon, J. A., Garcia-Sanz, R., Tabernero, M. D., Almeida, J., Gonzalez, M., Fernandez-Calvo, J., Moro, M. J., Hernandez, J. M., San Miguel, J. F., and Orfao, A. Prognostic value of numerical chromosome aberrations in multiple myeloma: a FISH analysis of 15 different chromosomes. Blood, 91: 3366-3371, 1998.
24. Laï, J. L., Michaux, L., Dastugue, N., Vasseur, F., Daudignon, A., Facon, T., Bauters, F., and Zandecki, M. Cytogenetics in multiple myeloma: a multicenter study of 24 patients with t(11;14)(q13;q32) or its variant. Cancer Genet. Cytogenet., 104: 133-138, 1998.
25. Fonseca, R., Witzig, T. E., Gertz, M. A., Kyle, R. A., Hoyer, J. D., Jalal, S. M., and Greipp, P. R. Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 cases. Br. J. Haematol., 101: 296-301, 1998.
26. Seong, C., Delasalle, K., Hayes, K., Weber, D., Dimopoulos, M., Swantkowski, J., Huh, Y., Glassman, A., Champlin, R., and Alexanian, R. Prognostic value of cytogenetics in multiple myeloma. Br. J. Haematol., 101: 189-195, 1998.